FDA Inspection 1062847 — Lacsa (Pty) Limited
The FDA completed an inspection of Lacsa (Pty) Limited on Jul 12, 2018 in Durban South. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 12, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Durban South (South Africa)